High Impact Publication Award, SAHMRI 2024

Eadie, Laura (Recipient) & Lagonik, Elias (Recipient)

Blood Cancer Program
Precision Cancer Medicine

Prize

Description

Joint Award to Dr Laura Eadie and PhD Student Elias Lagonik for their publication: Asciminib is a novel inhibitor of ABL1 and ABL2 gene fusions in ALL but requires the ABL SH3 domain for efficacy. Journal: Blood. 2024 Aug 29;144(9):1022-1026. doi: 10.1182/blood.2024024776.

Awarded date	5 Dec 2024
Degree of recognition	Local
Granting Organisations	South Australian Health and Medical Research Institute (SAHMRI)

Awarded at event

Event title	SAHMRI awards night
Location	SAHMRI, Adelaide, AustraliaShow on map
Period	7 Dec 2017